Zentalis Pharmaceuticals Inc
XNAS: ZNTL
Zentalis Pharmaceuticals Inc Live Stock Price Today, Share Analysis and Chart
about
Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing azenosertib (ZN-c3), a potentially first-in-class and best-in-class WEE1 inhibitor for patients with Cyclin E1-positive platinum-resistant ovarian cancer (Cyclin E1...
Read More
1.49
-0.07
(-4.49%)
505.5K
XNAS Volume
XNAS 12 Sep, 2025 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Neutral
Zentalis Pharmaceuticals Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..